Jiangzhong Pharmaceutical Co Ltd (600750) — Cash Flow Reinvestment Rate
Jiangzhong Pharmaceutical Co Ltd (600750) has a Cash Flow Reinvestment Rate of 0.29x as of September 2025, reinvesting CN¥95.46 Million (capex CN¥95.46 Million ) from operating cash flow of CN¥326.81 Million. Check cash flow quality index of Jiangzhong Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangzhong Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Jiangzhong Pharmaceutical Co Ltd across 26 annual periods. Explore 600750 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Jiangzhong Pharmaceutical Co Ltd (2000–2025)
Year-by-year capital reinvestment analysis for Jiangzhong Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 600750 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥377.57 Million | CN¥970.87 Million | CN¥280.57 Million | ▼ -49.0% |
| 2024 | 0.76x | CN¥599.39 Million | CN¥786.25 Million | CN¥290.77 Million | ▲ +135.1% |
| 2023 | 0.32x | CN¥335.91 Million | CN¥1.04 Billion | CN¥208.88 Million | ▼ -53.8% |
| 2022 | 0.70x | CN¥716.51 Million | CN¥1.02 Billion | CN¥345.64 Million | ▼ -57.0% |
| 2021 | 1.63x | CN¥1.50 Billion | CN¥917.04 Million | CN¥188.49 Million | ▲ +78.3% |
| 2020 | 0.92x | CN¥688.96 Million | CN¥752.50 Million | CN¥182.53 Million | ▼ -12.0% |
| 2019 | 1.04x | CN¥666.99 Million | CN¥641.18 Million | CN¥76.33 Million | ▲ +206.4% |
| 2018 | 0.34x | CN¥165.10 Million | CN¥486.25 Million | CN¥121.38 Million | ▼ -80.8% |
| 2017 | 1.77x | CN¥221.21 Million | CN¥124.93 Million | CN¥181.21 Million | ▲ +1582.0% |
| 2016 | 0.11x | CN¥73.49 Million | CN¥698.05 Million | CN¥70.07 Million | ▼ -69.7% |
| 2015 | 0.35x | CN¥177.25 Million | CN¥510.78 Million | CN¥62.75 Million | ▲ +21.0% |
| 2014 | 0.29x | CN¥102.33 Million | CN¥356.80 Million | CN¥102.33 Million | ▼ -50.3% |
| 2013 | 0.58x | CN¥64.59 Million | CN¥111.92 Million | CN¥64.59 Million | ▼ -41.8% |
| 2012 | 0.99x | CN¥224.42 Million | CN¥226.38 Million | CN¥224.42 Million | ▼ -32.6% |
| 2011 | 1.47x | CN¥247.55 Million | CN¥168.30 Million | CN¥247.55 Million | ▲ +132.1% |
| 2010 | 0.63x | CN¥140.86 Million | CN¥222.29 Million | CN¥140.86 Million | ▲ +1138.0% |
| 2009 | 0.05x | CN¥19.37 Million | CN¥378.32 Million | CN¥19.37 Million | ▼ -32.8% |
| 2008 | 0.08x | CN¥20.49 Million | CN¥268.87 Million | CN¥20.49 Million | ▲ +4.9% |
| 2007 | 0.07x | CN¥11.16 Million | CN¥153.63 Million | CN¥11.16 Million | ▼ -86.9% |
| 2006 | 0.56x | CN¥30.69 Million | CN¥55.24 Million | CN¥30.69 Million | ▲ +68.5% |
| 2005 | 0.33x | CN¥65.42 Million | CN¥198.45 Million | CN¥65.42 Million | ▼ -96.7% |
| 2004 | 10.01x | CN¥263.03 Million | CN¥26.28 Million | CN¥263.03 Million | ▲ +241.5% |
| 2003 | 2.93x | CN¥231.42 Million | CN¥78.98 Million | CN¥231.42 Million | ▲ +141.0% |
| 2002 | 1.22x | CN¥115.40 Million | CN¥94.90 Million | CN¥115.40 Million | ▲ +892.2% |
| 2001 | 0.12x | CN¥5.06 Million | CN¥41.28 Million | CN¥5.06 Million | ▼ -45.2% |
| 2000 | 0.22x | CN¥27.22 Million | CN¥121.77 Million | CN¥27.22 Million | — |